Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BIOSECURE Act
Pharma
Astellas, Takeda, RA Capital—Fierce Pharma Asia
Astellas CEO lays out the firm's new five-year plan. Takeda beats BMS in a psoriasis trial. RA provides China capabilities to its portfolio. And more.
Angus Liu
Jun 12, 2026 8:23am
WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
Jun 9, 2026 12:24pm
Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia
Dec 19, 2025 8:00am
Biosecure Act heads to Trump's desk after Senate vote
Dec 17, 2025 4:45pm
Pfizer-Fosun, Zealand, China's new formulary—Fierce Pharma Asia
Dec 12, 2025 8:15am
Biosecure Act slips into key US defense bill
Dec 9, 2025 11:00am
